BR0307236A - Processo para fabricação de compostos orgânicos - Google Patents

Processo para fabricação de compostos orgânicos

Info

Publication number
BR0307236A
BR0307236A BR0307236-3A BR0307236A BR0307236A BR 0307236 A BR0307236 A BR 0307236A BR 0307236 A BR0307236 A BR 0307236A BR 0307236 A BR0307236 A BR 0307236A
Authority
BR
Brazil
Prior art keywords
organic compounds
manufacturing organic
dihydroxyester
ketoester
hydroxy
Prior art date
Application number
BR0307236-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Guang-Pei Chen
Prasad Koteswara Kapa
Eric M Loeser
Ulrich Beutler
Werner Zaugg
Michael J Girgis
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR0307236A publication Critical patent/BR0307236A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Cephalosporin Compounds (AREA)
  • Quinoline Compounds (AREA)
BR0307236-3A 2002-01-28 2003-01-27 Processo para fabricação de compostos orgânicos BR0307236A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35231602P 2002-01-28 2002-01-28
US38318802P 2002-05-24 2002-05-24
PCT/EP2003/000804 WO2003064382A2 (en) 2002-01-28 2003-01-27 Process for the manufacture of organic compounds

Publications (1)

Publication Number Publication Date
BR0307236A true BR0307236A (pt) 2004-12-07

Family

ID=27669055

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0307236-3A BR0307236A (pt) 2002-01-28 2003-01-27 Processo para fabricação de compostos orgânicos

Country Status (19)

Country Link
US (3) US6835838B2 (https=)
EP (1) EP1472227B1 (https=)
JP (1) JP2005516064A (https=)
KR (2) KR20040077883A (https=)
CN (2) CN100378081C (https=)
AU (4) AU2003239294B2 (https=)
BR (1) BR0307236A (https=)
CA (1) CA2472340A1 (https=)
CO (1) CO5601045A2 (https=)
EC (1) ECSP045202A (https=)
IL (1) IL162817A0 (https=)
MX (1) MXPA04007308A (https=)
NO (1) NO327363B1 (https=)
NZ (3) NZ554366A (https=)
PL (1) PL371383A1 (https=)
RU (1) RU2360903C2 (https=)
SG (2) SG161742A1 (https=)
WO (1) WO2003064382A2 (https=)
ZA (1) ZA200405239B (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04000322A (es) 2001-07-13 2005-09-08 Astrazeneca Uk Ltd Preparacion de compuestos de aminopirimidina.
KR100919941B1 (ko) 2001-11-14 2009-10-05 닛산 가가쿠 고교 가부시키 가이샤 광학활성 옥소헵텐산 에스테르의 제조방법
PL370658A1 (en) * 2002-01-31 2005-05-30 Novartis Ag Process for the manufacture of hmg-coa reductase inhibitors
US7339062B2 (en) * 2002-09-20 2008-03-04 Nissan Chemical Industries, Ltd. Method for producing a 3,5-dihydroxy-6-heptenoate
CN101219992B (zh) * 2003-02-12 2011-08-31 日产化学工业株式会社 匹伐他汀钙的晶形
US7851624B2 (en) * 2003-12-24 2010-12-14 Teva Pharamaceutical Industries Ltd. Triol form of rosuvastatin and synthesis of rosuvastatin
TWI328006B (en) * 2003-12-26 2010-08-01 Nissan Chemical Ind Ltd Crystal form of quinoline compound and process for its production
CN1763015B (zh) * 2004-10-22 2011-06-22 四川抗菌素工业研究所有限公司 一种罗舒伐他汀及其药用盐的制备方法及中间体
GB0428328D0 (en) 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process
GB0514078D0 (en) * 2005-07-08 2005-08-17 Astrazeneca Uk Ltd Chemical process
EP2024341B1 (en) * 2006-05-03 2015-12-02 MSN Laboratories Private Limited Novel process for statins and its pharmaceutically acceptable salts thereof
US8404841B2 (en) * 2006-10-09 2013-03-26 Msn Laboratories Limited Process for the preparation of statins and their pharmaceutically acceptable salts thereof
TW200831469A (en) * 2006-12-01 2008-08-01 Astrazeneca Uk Ltd Chemical process
WO2010089770A2 (en) * 2009-01-19 2010-08-12 Msn Laboratories Limited Improved process for the preparation of highly pure (3r,5s)-7-[2-cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxy-6(e)-heptenoic acid and pharmaceutically acceptable salts thereof
RU2425034C1 (ru) * 2010-01-11 2011-07-27 Государственное образовательное учреждение высшего профессионального образования "Кубанский государственный технологический университет" (ГОУ ВПО "КубГТУ") Способ получения производных (e)-4-(6,7-диметокси-2-метил-3-хинолил)-3-бутен-2-она
US8987444B2 (en) 2010-01-18 2015-03-24 Msn Laboratories Private Limited Process for the preparation of amide intermediates and their use thereof
EP2423195A1 (en) 2010-07-26 2012-02-29 LEK Pharmaceuticals d.d. Process for the preparation of key intermediates for the synthesis of statins or pharmaceutically acceptable salts thereof
JP2013536219A (ja) * 2010-08-25 2013-09-19 カディラ・ヘルスケア・リミテッド ピタバスタチンカルシウムおよびその調製方法
EP3178812A1 (en) * 2010-11-12 2017-06-14 Hetero Research Foundation Novel polymorphs of pitavastatin calcium
WO2012140490A2 (en) 2011-04-11 2012-10-18 Aurobindo Pharma Limited Process for preparing quinoline derivative
CN103755568B (zh) * 2013-12-10 2015-10-28 江西科技师范大学 IeodomycinA和B立体选择性合成方法
US10676441B2 (en) 2015-08-05 2020-06-09 Api Corporation Method for producing pitavastatin calcium
CN108976168B (zh) * 2017-06-02 2020-09-25 浙江京新药业股份有限公司 一种匹伐他汀半钙盐晶型及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906624A (en) * 1987-09-08 1990-03-06 Warner-Lambert Company 6-(((Substituted)pyridin-3-yl)alkyl)-and alkenyl)-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
NZ230121A (en) * 1988-08-29 1993-08-26 Squibb & Sons Inc Pyridine and quinoline terminal groups for hmg-coenzyme a reductase inhibitors and pharmaceutical compositions for lowering blood serum cholesterol levels
JP3528186B2 (ja) 1991-06-24 2004-05-17 日産化学工業株式会社 光学活性キノリンメバロン酸のジアステレオマー塩
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
JP3130342B2 (ja) * 1991-10-04 2001-01-31 日産化学工業株式会社 動脈硬化性血管内膜肥厚抑制薬
JP3554036B2 (ja) * 1994-09-06 2004-08-11 宇部興産株式会社 光学活性な7−置換キノリル−3,5−ジヒドロキシ−ヘプト−6−エン酸エステル誘導体の製造方法
KR100919941B1 (ko) * 2001-11-14 2009-10-05 닛산 가가쿠 고교 가부시키 가이샤 광학활성 옥소헵텐산 에스테르의 제조방법
WO2008096257A1 (en) * 2007-02-08 2008-08-14 Aurobindo Pharma Limited An improved process for preparation of rosuvastatin calcium

Also Published As

Publication number Publication date
NZ554366A (en) 2008-11-28
US6835838B2 (en) 2004-12-28
NZ554367A (en) 2008-11-28
AU2006225206B2 (en) 2009-08-06
PL371383A1 (en) 2005-06-13
US7572917B2 (en) 2009-08-11
ZA200405239B (en) 2005-07-27
AU2003239294B2 (en) 2006-10-19
US20090299065A1 (en) 2009-12-03
NO327363B1 (no) 2009-06-15
EP1472227B1 (en) 2016-04-27
MXPA04007308A (es) 2004-10-29
KR20100091267A (ko) 2010-08-18
CN1660818A (zh) 2005-08-31
RU2360903C2 (ru) 2009-07-10
IL162817A0 (en) 2005-11-20
AU2009208129A1 (en) 2009-09-03
NZ534136A (en) 2007-08-31
US20030208072A1 (en) 2003-11-06
JP2005516064A (ja) 2005-06-02
US20040249154A1 (en) 2004-12-09
KR20040077883A (ko) 2004-09-07
AU2006225205A1 (en) 2006-10-26
RU2004126448A (ru) 2005-06-27
EP1472227A2 (en) 2004-11-03
CA2472340A1 (en) 2003-08-07
CO5601045A2 (es) 2006-01-31
AU2006225206A1 (en) 2006-10-26
WO2003064382A2 (en) 2003-08-07
NO20043586L (no) 2004-10-07
SG157225A1 (en) 2009-12-29
AU2006225205B2 (en) 2009-08-06
CN1625550A (zh) 2005-06-08
ECSP045202A (es) 2004-09-28
SG161742A1 (en) 2010-06-29
WO2003064382A3 (en) 2003-12-11
CN100378081C (zh) 2008-04-02

Similar Documents

Publication Publication Date Title
BR0307236A (pt) Processo para fabricação de compostos orgânicos
BR0017030A (pt) Derivados de tiazolilamida
BRPI0500480A (pt) processo para a sìntese de (1s)-4,5-dimetóxi- 1-(metilaminometil)-benzociclobutano e sais de adição deste, e aplicação na sìntese de ivabradina e sais de adição desta com um ácido farmaceuticamente aceitável
EA200300211A1 (ru) Азабициклические соединения, способ их получения и их применение в качестве лекарственных средств, в частности в качестве антибактериальных средств
BR0213380A (pt) Derivados propiÈnicos alfa-oxissubstituìdos por beta-fenila: processo para sua preparação e seu uso na preparação de compostos farmaceuticamente importantes
CL2010000284A1 (es) Procedimientos para la preparacion de 4-(2-cianoetenil)-2,6-dimetilanilina a partir de 2,6-dimetil-4-sustituida-anilina. (divisional de solicitud 2003-01598)
BR0112538A (pt) Sais estáveis de ácido o-acetilsalicìlico com aminoácidos básicos
ECSP056071A (es) Nueva difenilazetidinona con características fisiológicas mejoradas, correspondiente método de producción, medicamentos que contienen dicho compuesto y su uso
BRPI0108990B8 (pt) processo para preparação de derivados de pirimidona com atividade antifungos
BR9808854A (pt) Processo para preparação de um composto, e, composto
BR0215097A (pt) Processo para fazer o composto da fórmula e composto da fórmula
BR0011996A (pt) Preparação de piperidin-4-onas substituìdas
NO20040388L (no) Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten
PT1385850E (pt) Novo processo para a preparacao de oxabispidinas
BR0114437A (pt) Derivados de acido propiÈnico
BR0113259A (pt) Processo para a preparação de um composto, composto e processo para a preparação de compostos
PL1654284T3 (pl) Sposób uzyskiwania roztworu alfa-1-antytrypsyny
BR0212390A (pt) Processo para a preparação de cilastatina
TW200716582A (en) Process for making a pharmaceutical compound
BR0311699A (pt) Processo para a decomposição de hidroperóxido de cicloexila
BRPI0507979A (pt) processo para preparação de um composto
BRPI0411717A (pt) processo para a preparação de acilsulfamoibenzamidas
BRPI0407448A (pt) Processo quìmico
BR0009453B1 (pt) processo para a preparação de um composto.
BR0314306A (pt) Processo para produção de um álcool pela hidrogenação de um aldeìdo alifático sobre um catalisador

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]